Oto T, Kiura K, Toyooka S, Miyoshi S. Basal segmental autotransplantation after pneumonectomy for advanced central lung cancer. Eur J Cardiothorac Surg. 2012;42(3):579–81. https://doi.org/10.1093/ejcts/ezs224.
Wang B, Wang J, Sun T, Ding Y, Li S, Lu H. Innovative Techniques in Video-Assisted Thoracoscopic Surgery: Lu's Approach. Lung Cancer (Auckl). 2024;15:9–17. Published 2024 Feb 2. https://doi.org/10.2147/LCTT.S446418.
Baumann L, Petersen RH, Hansen H, Hansen O. Outcome after pneumonectomy for non-small cell lung cancer: A comparison of a contemporary series with earlier results. Eur J Cardiothorac Surg. 2015;48(2):287–92.
Chida M, Kobayashi S, Karube Y, Hayama M, Tamura M, Ishikawa Y, Miyoshi S. Long-term outcomes after pneumonectomy for lung cancer in elderly patients. World J Surg Oncol. 2016;14(1):1–9.
D’Andrilli A, Venuta F, Rendina EA, Anile M. Impact of extended pneumonectomy for lung cancer on postoperative quality of life and long-term survival. J Thorac Cardiovasc Surg. 2014;148(5):2006–12.
Filosso PL, Guerrera F, Bora G, Oliaro A. The role of sleeve resections in central lung tumors: a review. J Thorac Dis. 2015;7(Suppl 2):S198–208.
Zhou H, Tapias LF, Gaissert HA, Mathisen DJ, Wright CD. Sleeve lobectomy and pneumonectomy: functional outcomes and quality of life. Ann Thorac Surg. 2017;103(5):1598–605.
Kamel MK, Lee B, Harrison S, Port JL, Altorki NK. Outcomes of double sleeve lobectomy for lung cancer: A single institution experience. Ann Thorac Surg. 2019;107(3):930–6.
Karube Y, Chida M, Nishihira M, et al. Back-table procedure and auto-lung transplantation for locally advanced lung cancer: a case report. J Cardiothorac Surg. 2016;11:3.
Article PubMed PubMed Central Google Scholar
Nakajima D, Ohsumi A, Hamaji M, Chen-Yoshikawa TF, Date H. Expanded indications for auto-lung transplant technique. Gen Thorac Cardiovasc Surg. 2020;68(8):828–32.
Jiang F, Xu L, Yuan FL, Huang JF, Lu XX. Lung autotransplantation technique in the treatment for central lung cancer of upper lobe. J Thorac Oncol 2008;3(6):609–11. https://doi.org/10.1097/JTO.0b013e31817589a8.
Mao W, Xia W, Chen J, Zheng M. Successful lung autotransplantation for central non-small-cell lung cancer: report of a case. Surg Today. 2013;43(5):562–5. https://doi.org/10.1007/s00595-012-0247-0.
Watanabe Y, Sato M, Nakamura Y, Hoshikawa Y, Harada A, Nagata T, Yotsumoto G, Imoto Y, Okada Y, Kondo T. Right lower lobe autotransplantation for locally advanced central lung cancer. Ann Thorac Surg. 2015;99(1):323–6. https://doi.org/10.1016/j.athoracsur.2014.02.065.
Tanaka S, Sugimoto S, Soh J, Oto T. Long-term outcomes of pneumonectomy, back-table lung preservation, double-sleeve resection and reimplantation for advanced central lung cancer: the Oto procedure. Eur J Cardiothorac Surg. 2019;56(1):213–4. https://doi.org/10.1093/ejcts/ezy431.
Nakajima D, Ohsumi A, Hamaji M, Chen-Yoshikawa TF, Date H. Expanded indications for auto-lung transplant technique. Gen Thorac Cardiovasc Surg. 2020;68(8):828–32. https://doi.org/10.1007/s11748-020-01289-3.
He J, Yang C, Suen HC, He J, Li S. A novel lung autotransplantation technique for treating central lung cancer: a case report. Transl Lung Cancer Res. 2021;10(5):2290–7. https://doi.org/10.21037/tlcr-20-1242.
Taira A, Nawashiro A, Takeda Y, Shinohara S, Takenaka M, Kuroda K, Oto T, Tanaka F. Lung Autotransplantation for Bulky Superior Sulcus Tumor With Hilar Involvement. Ann Thorac Surg. 2022;114(2):e97–9. https://doi.org/10.1016/j.athoracsur.2021.10.062.
Fuso L, Varone F, Nachira D, Leli I, Salimbene I, Congedo MT, Margaritora S, Granone P. Incidence and Management of Post-Lobectomy and Pneumonectomy Bronchopleural Fistula. Lung. 2016;194(2):299–305. https://doi.org/10.1007/s00408-016-9841-z.
Peng Z, Mei J, Liu C, Guo C, Gonzalez M, Bölükbas S, Voltolini L, Pu Q, Liu L. Risk factors and outcomes of bronchopleural fistula after bronchoplasty in patients with non-small cell lung cancer: a retrospective multivariate analysis. Transl Lung Cancer Res. 2022;11(5):744–56. https://doi.org/10.21037/tlcr-22-272.
Article PubMed PubMed Central CAS Google Scholar
Dai J, Zhu X, Li D, Huang Y, Liu X, He W, Duan L, Zhao D, Zhu Y, Chen C, Provencio M, Ramirez RA, Antonoff MB, Wu C, Jiang G. Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancer. Transl Lung Cancer Res. 2022;11(2):188–200. https://doi.org/10.21037/tlcr-22-56.
Article PubMed PubMed Central CAS Google Scholar
Zhao R, Guan X, Zhang P, Liu Y, Xu Y, Sun C, Qiu S, Zhu W, Yang Z, Wang X. Development of postoperative bronchopleural fistula after neoadjuvant immunochemotherapy in non-small cell lung cancer: case reports and review of the literature. J Cancer Res Clin Oncol. 2024;150(4):175. https://doi.org/10.1007/s00432-024-05683-9.
Article PubMed PubMed Central Google Scholar
Sumi T, Ikeda T, Kure K, Yamada Y, Nakata H, Mori Y. Bronchomediastinal Fistula During Durvalumab Therapy After Chemoradiotherapy in Stage III NSCLC. J Thorac Oncol. 2019;14(10):1860–1. https://doi.org/10.1016/j.jtho.2019.06.003.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, CheckMate 816 Investigators. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. New England J Med. 2022;386(21):1973–85. https://doi.org/10.1056/NEJMoa2202170.
Provencio M, Serna-Blasco R, Nadal E, Insa A, García-Campelo MR, Casal Rubio J, Dómine M, Majem M, Rodríguez-Abreu D, Martínez-Martí A, De Castro Carpeño J, Cobo M, López Vivanco G, Del Barco E, Bernabé Caro R, Viñolas N, Barneto Aranda I, Viteri S, Pereira E, Royuela A, Romero A. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial). J Clin Oncol. 2022;40(25):2924–33. https://doi.org/10.1200/JCO.21.02660.
Article PubMed PubMed Central CAS Google Scholar
Zhang W, Liang Z, Zhao Y, Li Y, Chen T, Li W, Chen Y, Wu P, Zhang H, Fang C, Li L. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials. Front Immunol. 2024;15:1359302. https://doi.org/10.3389/fimmu.2024.1359302.
留言 (0)